Latest news
Oral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTWoman Find Relief After Psoriasis Left Her In Constant Pain - SurvivorNetSurvivorNet · Fri, 31 Jul 2026 22:44:19 GMTFirst Oral IL-23 Blocker Gets EMA Nod for Plaque Psoriasis - MedscapeMedscape · Tue, 28 Jul 2026 11:42:38 GMT